Literature DB >> 6096396

Oxygen metabolism in phagocytes of leprotic patients: enhanced endogenous superoxide dismutase activity and hydroxyl radical generation by clofazimine.

Y Niwa, T Sakane, Y Miyachi, M Ozaki.   

Abstract

We examined the generation of active oxygens (O2-, H2O2, and OH X ) and the superoxide dismutase (SOD) activity of polymorphonuclear leukocytes (PMNs) and monocytes from 14 leprotic patients manifesting a bacillary index above 2.2. Patients with disease of more than 4 years in duration showed significantly enhanced SOD activity and a decrease in O2- and OH X production. The antileprotic agent, clofazimine, significantly increased the generation of OH X in a dose-dependent manner, with a subsequent decrease in H2O2, but had no effect on the SOD activity of the PMNs and monocytes. In medium containing FeSO4 or Fe2+-EDTA, the drug elevated OH X production markedly further. Phagocytic SOD in PMNs and monocytes of leprotic patients was both host and bacillus derived, because the presence of cyanide, to which human-derived cuprozinc SOD is susceptible, did not completely abrogate SOD activity. The difficulty in treating leprosy may be partly ascribable to decreased phagocytic OH X generation, which in leprosy patients is apparently due to the uptake of Hansen bacillus-derived SOD. Clofazimine may be effective in leprosy by chelating Fe2+, with the resultant potentiation of the catalyzing activity of Fe2+ in the Haber-Weiss reaction increasing OH X formation from H2O2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096396      PMCID: PMC271453          DOI: 10.1128/jcm.20.5.837-842.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Free radicals and inflammation. Protection of phagocytosine leukocytes by superoxide dismutase.

Authors:  M L Salin; J M McCord
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

2.  Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine.

Authors:  J COCHIN; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1959-02       Impact factor: 4.030

3.  Defective leukotaxis in patients with lepromatous leprosy.

Authors:  P A Ward; S Goralnick; W E Bullock
Journal:  J Lab Clin Med       Date:  1976-06

4.  Preparation and assay of superoxide dismutases.

Authors:  J D Crapo; J M McCord; I Fridovich
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

5.  Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.

Authors:  Y Niwa; S Miyake; T Sakane; M Shingu; M Yokoyama
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

6.  Superoxide dismutase from Mycobacterium species, strain Takeo.

Authors:  M Kusunose; Y Noda; K Ichihara; E Kusunose
Journal:  Arch Microbiol       Date:  1976-05-03       Impact factor: 2.552

7.  NADPH-dependent production of oxy radicals by purified components of the rat liver mixed function oxidase system. I. Oxidation of hydroxyl radical scavenging agents.

Authors:  G W Winston; A I Cederbaum
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

8.  Treatment of pustulosis palmaris et plantaris with oral doses of colchicine.

Authors:  M Takigawa; Y Miyachi; M Uehara; H Tagami
Journal:  Arch Dermatol       Date:  1982-07

9.  Pyoderma gangrenosum treated with clofazimine. Report of three cases.

Authors:  E C Kark; B R Davis; J R Pomeranz
Journal:  J Am Acad Dermatol       Date:  1981-02       Impact factor: 11.527

10.  [Increase in dismutase activity in splenic leukocytes of mice sensitive to BCG and Mycobacterium lepraemurium].

Authors:  J L Stach; F Fumoux; M Strobel; A Baret; M Michelson
Journal:  C R Seances Acad Sci III       Date:  1981-11-16
View more
  9 in total

1.  THERAPEUTIC HYPERBARIC OXYGENATION AS AN ADJUNCT TO MULTIDRUG THERAPY IN HANSEN'S DISEASE.

Authors:  Plk DE Sylva; S Nangpal; M J John; K M Shah; S Bhattacharya; H Mani; A K Hukkoo; C Saxena
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species.

Authors:  Takahiro Yano; Sacha Kassovska-Bratinova; J Shin Teh; Jeffrey Winkler; Kevin Sullivan; Andre Isaacs; Norman M Schechter; Harvey Rubin
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

3.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.

Authors:  T J Holzer; K E Nelson; R G Crispen; B R Andersen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

4.  Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo.

Authors:  N H Afdhal; A Long; J Lennon; J Crowe; D P O'Donoghue
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 5.  Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.

Authors:  W M Meyers; A M Marty
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

6.  Apoptosis-inducing activity of clofazimine in macrophages.

Authors:  Yasuo Fukutomi; Yumi Maeda; Masahiko Makino
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

7.  Experimental burn-induced changes in lipid peroxide levels, and activity of superoxide dismutase and glutathione peroxidase in skin lesions, serum, and liver of mice.

Authors:  S Kawai; J Komura; Y Asada; Y Niwa
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

8.  Iron sequestration by macrophages decreases the potential for extracellular hydroxyl radical formation.

Authors:  O Olakanmi; S E McGowan; M B Hayek; B E Britigan
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

9.  Mononuclear phagocytes have the potential for sustained hydroxyl radical production. Use of spin-trapping techniques to investigate mononuclear phagocyte free radical production.

Authors:  B E Britigan; T J Coffman; D R Adelberg; M S Cohen
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.